...
首页> 外文期刊>Clinical rheumatology >Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate.
【24h】

Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate.

机译:甲氨蝶呤治疗的类风湿性关节炎患者持久消除了艾滋病毒阴性的卡波西氏肉瘤疱疹病毒相关的卡波西氏肉瘤。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Multicentric Castleman disease (MCD) is a nonneoplastic lymphoproliferative disorder that has a poor prognosis. Optimal treatment is unknown. There are a few reported cases of MCD and rheumatoid arthritis. In this study, we report a patient with rheumatoid arthritis diagnosed with Kaposi's sarcoma herpesvirus-(KSHV, human herpesvirus-8) associated MCD that showed expression of viral IL-6. Treatment with methotrexate (MTX) resulted in a complete remission of her disease lasting for 54+ months. Multiple studies have suggested that MCD and rheumatoid arthritis are associated with overexpression of the growth-promoting cytokine interleukin-6 (IL-6), and that MTX downregulates the production of this cytokine in vivo. As such, we suggest that the dramatic improvement in this patient's disease is due to the immunomodulatory properties of MTX.
机译:多中心Castleman病(MCD)是一种非肿瘤性淋巴增生性疾病,预后较差。最佳治疗尚不清楚。有一些报道的MCD和类风湿关节炎病例。在这项研究中,我们报告了一名风湿性关节炎患者,其诊断为卡波西氏肉瘤疱疹病毒(KSHV,人类疱疹病毒8)相关的MCD,表达病毒IL-6。甲氨蝶呤(MTX)治疗可使她的疾病完全缓解,持续54个月以上。多项研究表明,MCD和类风湿性关节炎与促进生长的细胞因子白介素6(IL-6)的过表达有关,MTX在体内下调了这种细胞因子的产生。因此,我们认为该患者疾病的显着改善归因于MTX的免疫调节特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号